Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

PolyScience Baths Have Various Sizes, Capabilities

By Drug Discovery Trends Editor | April 9, 2013

PolyScience Refrigerated Circulating BathsAvailable in 40 different models, the PolyScience line of refrigerating/heating circulating baths features temperature ranges as broad as -40 degrees to +200 degrees C, temperature stabilities as exacting as ±0.005 degrees C, and reservoir sizes ranging from 7 to 75 liters. Six different temperature controllers are available, including two with time/temperature programming capability. Designed with the work habits and needs of laboratory personnel in mind, the baths incorporate many ergonomic features to make life in the lab more productive and efficient. Design innovations include a swiveling control head that permits viewing of the temperature display anywhere within a 180-degree viewing radius, an integral lid docking system for no-mess reservoir cover storage and a corrosion and chemical resistant top plate that dampens noise and remains cooler at high temperatures. Among the temperature controllers available are PolyScience’s Performance Programmable, Performance Digital, Advanced Programmable, Advanced Digital, Standard Digital and MX models. All feature extra-large digital readouts, highly intuitive operation and calibration capability.   
 
PolyScience, 800-229-7569, www.polyscience.com

Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE